Stockscreener 앱 받기
104.87
0.61%
0.64
시간 외 거래:
104.55
-0.32
-0.31%
Celcuity Inc 주식(CELC)의 최신 뉴스
Celcuity Adds Veteran Director to Strengthen Oncology Strategy - TipRanks
Celcuity Appoints Charles Romp to its Board of Directors - GlobeNewswire
Discipline and Rules-Based Execution in CELC Response - Stock Traders Daily
Celcuity CEO Sets July 17 PDUFA for Gedatolisib, Teases VIKTORIA-1 Mutant Data at Conference - MarketBeat
CELC: Gedatolisib nears approval with strong efficacy, broad utility, and major commercial potential - TradingView
Candriam S.C.A. Increases Holdings in Celcuity, Inc. $CELC - MarketBeat
Inflation Data: Does Celcuity Inc align with a passive investing strategyJuly 2025 Pullbacks & Free Safe Entry Trade Signal Reports - baoquankhu1.vn
Published on: 2026-02-08 07:23:47 - baoquankhu1.vn
Director Sells 20,000 Celcuity Shares for $2.4 Million Following 933% Share Price Jump - The Globe and Mail
Director Sells 20,000 Celcuity Shares for $2.4 Million Following 933% Share Price Jump - The Motley Fool
Wall Street Recap: Is Celcuity Inc stock a smart retirement pickGold Moves & Step-by-Step Swing Trade Plans - baoquankhu1.vn
Profit Review: Can Celcuity Inc ride the EV wave2025 Valuation Update & Breakout Confirmation Alerts - baoquankhu1.vn
Assessing Celcuity (CELC) Valuation After Recent Share Price Momentum And DCF Upside Estimate - Yahoo Finance
Wolfe Research recommends buying Celcuity stock on weakness related to external catalyst By Investing.com - Investing.com South Africa
Wolfe Research recommends buying Celcuity stock on weakness related to external catalyst - Investing.com Canada
Biotech Stocks To ResearchFebruary 4th - MarketBeat
Celcuity to Present at Upcoming Guggenheim Emerging Outlook: Biotech Summit 2026 - The Manila Times
Wealth Enhancement Advisory Services LLC Sells 10,476 Shares of Celcuity, Inc. $CELC - MarketBeat
Celcuity (CELC) Draws Investor Attention as Precision Oncology Strategy Advances - Insider Monkey
Jobs Data: Whats the beta of Celcuity Inc stockTrade Entry Report & Community Trade Idea Sharing Platform - baoquankhu1.vn
Behavioral Patterns of CELC and Institutional Flows - Stock Traders Daily
Atle Fund Management AB Takes $1.84 Million Position in Celcuity, Inc. $CELC - MarketBeat
Celcuity granted FDA priority review for breast cancer therapy - MSN
Celcuity prices $248.7M debt, stock offerings - MSN
Celcuity Inc. (CELC) Stock Analysis: Navigating High Potential in Biotechnology with a $5.19 Billion Market Cap - DirectorsTalk Interviews
Assessing Celcuity (CELC) Valuation After FDA Priority Review Milestone For Gedatolisib - Sahm
Celcuity (NASDAQ:CELC) Director Sells $2,400,600.00 in Stock - MarketBeat
Celcuity stock hits all-time high at 116.65 USD By Investing.com - Investing.com Australia
Celcuity (CELC) Is Up 11.3% After FDA Grants Priority Review To Gedatolisib NDAWhat's Changed - simplywall.st
Celcuity (NASDAQ:CELC) Reaches New 52-Week HighTime to Buy? - MarketBeat
Celcuity stock hits all-time high at 116.65 USD - Investing.com
Celcuity Inc. Earnings Call: Strong Progress Amid Challenges - MSN
Celcuity, Inc. (NASDAQ:CELC) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
Celcuity Inc: A Die To Be Cast Before July 2026 (NASDAQ: CELC) - Seeking Alpha
Celcuity Inc. (CELC) Stock Analysis: Exploring the Biotechnology Innovator’s Growth Potential - DirectorsTalk Interviews
Reassessing Celcuity (CELC) Valuation After A 51.85% Three Month Share Price Gain - Yahoo Finance
(CELC) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
FDA accepts Celcuity’s NDA for gedatolisib with priority review By Investing.com - Investing.com South Africa
Celcuity wins FDA review for breast cancer drug (CELC:NASDAQ) - Seeking Alpha
FDA Accepts Celcuity's NDA For Gedatolisib In HR+, HER2- Advanced Breast Cancer - Nasdaq
FDA accepts Celcuity’s NDA for gedatolisib with priority review - Investing.com
Celcuity Announces FDA Acceptance of New Drug Application for Gedatolisib in HR+/HER2-/PIK3CA Wild-Type Advanced Breast Cancer - manilatimes.net
Short Interest in Celcuity, Inc. (NASDAQ:CELC) Expands By 20.9% - MarketBeat
Is Celcuity Inc. stock gaining market shareEarnings Growth Summary & Daily Profit Maximizing Trade Tips - bollywoodhelpline.com
Dow Update: Can POAI lead its sector in growth2025 Valuation Update & Long-Term Safe Investment Ideas - baoquankhu1.vn
Merger Talk: Is Madison Square Garden Sports Corp stock forming a cup and handleJuly 2025 Rallies & AI Forecasted Entry/Exit Points - baoquankhu1.vn
Chart Watch: Can Celcuity Inc disrupt its industryJuly 2025 Final Week & Fast Entry Momentum Trade Alerts - baoquankhu1.vn
Nisa Investment Advisors LLC Buys 14,930 Shares of Celcuity, Inc. $CELC - MarketBeat
Celcuity (NASDAQ:CELC) Shares Down 6.2%Should You Sell? - MarketBeat
This Pharma Stock Rose 200% On Monday Morning And Retail Says Valuation Could Rise To $5B: Here’s Why - MSN
1.24%
0.19%
자본화:
|
볼륨(24시간):